23. CBD products which fulfill the definition of the CBPM will likely be Class B managed prescription drugs and subject to Regulation 16A along with the applicable constraints for Agenda two medications [footnote 5]. CBD products which meet the definition of the cannabis-dependent drugs that's been separately scheduled will likely be Class B medici